---
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_STUDYID
  :ordinal: 1
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Study Identifier
  :name: STUDYID
  :format: ''
  :notes: Unique identifier for a study.
  :compliance: Required
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_DOMAIN
  :ordinal: 2
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Domain Abbreviation
  :name: DOMAIN
  :format: "(DOMAIN)"
  :notes: Two-character abbreviation for the domain.
  :compliance: Required
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_USUBJID
  :ordinal: 3
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Unique Subject Identifier
  :name: USUBJID
  :format: ''
  :notes: Identifier used to uniquely identify a subject across all studies for all
    applications or submissions involving the product.
  :compliance: Required
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESEQ
  :ordinal: 4
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Sequence Number
  :name: AESEQ
  :format: ''
  :notes: Sequence Number given to ensure uniqueness of subject records within a domain.
    May be any valid number.
  :compliance: Required
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEGRPID
  :ordinal: 5
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Group ID
  :name: AEGRPID
  :format: ''
  :notes: Used to tie together a block of related records in a single domain for a
    subject.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEREFID
  :ordinal: 6
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Reference ID
  :name: AEREFID
  :format: ''
  :notes: Internal or external identifier such as a serial number on an SAE reporting
    form.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESPID
  :ordinal: 7
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Sponsor-Defined Identifier
  :name: AESPID
  :format: ''
  :notes: 'Sponsor-defined identifier. It may be pre-printed on the CRF as an explicit
    line identifier or defined in the sponsor’s operational database. Example: Line
    number on an Adverse Events page.'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AETERM
  :ordinal: 8
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Reported Term for the Adverse Event
  :name: AETERM
  :format: ''
  :notes: Verbatim name of the event.
  :compliance: Required
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEMODIFY
  :ordinal: 9
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Modified Reported Term
  :name: AEMODIFY
  :format: ''
  :notes: If AETERM is modified to facilitate coding, then AEMODIFY will contain the
    modified text.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AELLT
  :ordinal: 10
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Lowest Level Term
  :name: AELLT
  :format: MedDRA
  :notes: Dictionary-derived text description of the Lowest Level Term.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AELLTCD
  :ordinal: 11
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Lowest Level Term Code
  :name: AELLTCD
  :format: MedDRA
  :notes: Dictionary-derived code for the Lowest Level Term.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEDECOD
  :ordinal: 12
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Dictionary-Derived Term
  :name: AEDECOD
  :format: MedDRA
  :notes: Dictionary-derived text description of AETERM or AEMODIFY. Equivalent to
    the Preferred Term (PT in MedDRA). The sponsor is expected to provide the dictionary
    name and version used to map the terms utilizing the define.xml external codelist
    attributes.
  :compliance: Required
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEPTCD
  :ordinal: 13
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Preferred Term Code
  :name: AEPTCD
  :format: MedDRA
  :notes: Dictionary-derived code for the Preferred Term.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEHLT
  :ordinal: 14
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: High Level Term
  :name: AEHLT
  :format: MedDRA
  :notes: Dictionary-derived text description of the High Level Term for the primary
    System Organ Class.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEHLTCD
  :ordinal: 15
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: High Level Term Code
  :name: AEHLTCD
  :format: MedDRA
  :notes: Dictionary-derived code for the High Level Term for the primary System Organ
    Class.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEHLGT
  :ordinal: 16
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: High Level Group Term
  :name: AEHLGT
  :format: MedDRA
  :notes: Dictionary-derived text description of the High Level Group Term for the
    primary System Organ Class.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEHLGTCD
  :ordinal: 17
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: High Level Group Term Code
  :name: AEHLGTCD
  :format: MedDRA
  :notes: Dictionary-derived code for the High Level Group Term for the primary System
    Organ Class.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AECAT
  :ordinal: 18
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Category for Adverse Event
  :name: AECAT
  :format: ''
  :notes: 'Used to define a category of related records. Example: BLEEDING, NEUROPSYCHIATRIC.'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESCAT
  :ordinal: 19
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Subcategory for Adverse Event
  :name: AESCAT
  :format: ''
  :notes: 'A further categorization of adverse event. Example: NEUROLOGIC.'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEPRESP
  :ordinal: 20
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Pre-Specified Adverse Event
  :name: AEPRESP
  :format: "(NY)"
  :notes: A value of “Y” indicates that this adverse event was pre-specified on the
    CRF. Values are null for spontaneously reported events (i.e., those collected
    as free-text verbatim terms)
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEBODSYS
  :ordinal: 21
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Body System or Organ Class
  :name: AEBODSYS
  :format: ''
  :notes: Dictionary derived. Body system or organ class used by the sponsor from
    the coding dictionary (e.g., MedDRA). When using a multi-axial dictionary such
    as MedDRA, this should contain the SOC used for the sponsor’s analyses and summary
    tables which may not necessarily be the primary SOC.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEBDSYCD
  :ordinal: 22
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Body System or Organ Class Code
  :name: AEBDSYCD
  :format: MedDRA
  :notes: Dictionary derived. Code for the body system or organ class used by the
    sponsor. When using a multi-axial dictionary such as MedDRA, this should contain
    the SOC used for the sponsor’s analyses and summary tables, which may not necessarily
    be the primary SOC.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESOC
  :ordinal: 23
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Primary System Organ Class
  :name: AESOC
  :format: MedDRA
  :notes: Dictionary-derived text description of the primary System Organ Class. Will
    be the same as AEBODSYS if the primary SOC was used for analysis.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESOCCD
  :ordinal: 24
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Primary System Organ Class Code
  :name: AESOCCD
  :format: MedDRA
  :notes: Dictionary-derived code for the primary System Organ Class. Will be the
    same as AEBDSYCD if the primary SOC was used for analysis.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AELOC
  :ordinal: 25
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Location of Event
  :name: AELOC
  :format: "(LOC)"
  :notes: Describes anatomical location relevant for the event (e.g., ARM for skin
    rash).
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESEV
  :ordinal: 26
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Severity/Intensity
  :name: AESEV
  :format: "(AESEV)"
  :notes: 'The severity or intensity of the event. Examples: MILD, MODERATE, SEVERE.'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESER
  :ordinal: 27
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Serious Event
  :name: AESER
  :format: "(NY)"
  :notes: Is this a serious event?
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEACN
  :ordinal: 28
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Action Taken with Study Treatment
  :name: AEACN
  :format: "(ACN)"
  :notes: 'Describes changes to the study treatment as a result of the event. AEACN
    is specifically for the relationship to study treatment. AEACNOTH is for actions
    unrelated to dose adjustments of study treatment. Examples of AEACN values include
    ICH E2B values: DRUG WITHDRAWN, DOSE REDUCED, DOSE INCREASED, DOSE NOT CHANGED,
    UNKNOWN or NOT APPLICABLE.'
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEACNOTH
  :ordinal: 29
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Other Action Taken
  :name: AEACNOTH
  :format: ''
  :notes: 'Describes other actions taken as a result of the event that are unrelated
    to dose adjustments of study treatment. Usually reported as free text. Example:
    “TREATMENT UNBLINDED. PRIMARY CARE PHYSICIAN NOTIFIED.”'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEREL
  :ordinal: 30
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Causality
  :name: AEREL
  :format: ''
  :notes: Records the investigator's opinion as to the causality of the event to the
    treatment. ICH E2A and E2B examples include NOT RELATED, UNLIKELY RELATED, POSSIBLY
    RELATED, RELATED. Controlled Terminology may be defined in the future. Check with
    regulatory authority for population of this variable.
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AERELNST
  :ordinal: 31
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Relationship to Non-Study Treatment
  :name: AERELNST
  :format: ''
  :notes: 'Records the investigator''s opinion as to whether the event may have been
    due to a treatment other than study drug. May be reported as free text. Example:
    "MORE LIKELY RELATED TO ASPIRIN USE.”.'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEPATT
  :ordinal: 32
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Pattern of Adverse Event
  :name: AEPATT
  :format: ''
  :notes: 'Used to indicate the pattern of the event over time. Examples: INTERMITTENT,
    CONTINUOUS, SINGLE EVENT.'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEOUT
  :ordinal: 33
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Outcome of Adverse Event
  :name: AEOUT
  :format: "(OUT)"
  :notes: Description of the outcome of an event.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESCAN
  :ordinal: 34
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Involves Cancer
  :name: AESCAN
  :format: "(NY)"
  :notes: Was the serious event associated with the development of cancer?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESCONG
  :ordinal: 35
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Congenital Anomaly or Birth Defect
  :name: AESCONG
  :format: "(NY)"
  :notes: Was the serious event associated with congenital anomaly or birth defect?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESDISAB
  :ordinal: 36
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Persist or Signif Disability/Incapacity
  :name: AESDISAB
  :format: "(NY)"
  :notes: Did the serious event result in persistent or significant disability/incapacity?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESDTH
  :ordinal: 37
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Results in Death
  :name: AESDTH
  :format: "(NY)"
  :notes: Did the serious event result in death?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESHOSP
  :ordinal: 38
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Requires or Prolongs Hospitalization
  :name: AESHOSP
  :format: "(NY)"
  :notes: Did the serious event require or prolong hospitalization?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESLIFE
  :ordinal: 39
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Is Life Threatening
  :name: AESLIFE
  :format: "(NY)"
  :notes: Was the serious event life threatening?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESOD
  :ordinal: 40
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Occurred with Overdose
  :name: AESOD
  :format: "(NY)"
  :notes: Did the serious event occur with an overdose?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESMIE
  :ordinal: 41
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Other Medically Important Serious Event
  :name: AESMIE
  :format: "(NY)"
  :notes: Do additional categories for seriousness apply?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AECONTRT
  :ordinal: 42
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Concomitant or Additional Trtmnt Given
  :name: AECONTRT
  :format: "(NY)"
  :notes: Was another treatment given because of the occurrence of the event?
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AETOXGR
  :ordinal: 43
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Standard Toxicity Grade
  :name: AETOXGR
  :format: ''
  :notes: Toxicity grade according to a standard toxicity scale such as Common Terminology
    Criteria for Adverse Events v3.0 (CTCAE). Sponsor should specify name of the scale
    and version used in the metadata (see Assumption 6d). If value is from a numeric
    scale, represent only the number (e.g., “2” and not “Grade 2”).
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESTDTC
  :ordinal: 44
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Start Date/Time of Adverse Event
  :name: AESTDTC
  :format: ISO 8601
  :notes: ''
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEENDTC
  :ordinal: 45
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: End Date/Time of Adverse Event
  :name: AEENDTC
  :format: ISO 8601
  :notes: ''
  :compliance: Expected
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AESTDY
  :ordinal: 46
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Study Day of Start of Adverse Event
  :name: AESTDY
  :format: ''
  :notes: Study day of start of adverse event relative to the sponsor-defined RFSTDTC.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEENDY
  :ordinal: 47
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Study Day of End of Adverse Event
  :name: AEENDY
  :format: ''
  :notes: Study day of end of event relative to the sponsor-defined RFSTDTC.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEDUR
  :ordinal: 48
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: Duration of Adverse Event
  :name: AEDUR
  :format: ISO 8601
  :notes: 'Collected duration and unit of an adverse event. Used only if collected
    on the CRF and not derived from start and end date/times. Example: P1DT2H (for
    1 day, 2 hours).'
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEENRF
  :ordinal: 49
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: End Relative to Reference Period
  :name: AEENRF
  :format: "(STENRF)"
  :notes: Describes the end of the event relative to the sponsor-defined reference
    period. The sponsor-defined reference period is a continuous period of time defined
    by a discrete starting point (RFSTDTC) and a discrete ending point (RFENDTC) of
    the trial.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEENRTPT
  :ordinal: 50
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: End Relative to Reference Time Point
  :name: AEENRTPT
  :format: "(STENRF)"
  :notes: Identifies the end of the event as being before or after the reference time
    point defined by variable AEENTPT.
  :compliance: Permissible
- :uri: http://www.assero.co.uk/MDRSdtmIgD/CDISC/V3#IG-CDISC_SDTMIGAE_AEENTPT
  :ordinal: 51
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmDomainVariable
  :label: End Reference Time Point
  :name: AEENTPT
  :format: ''
  :notes: 'Description of date/time in ISO 8601 character format of the reference
    point referred to by AEENRTPT. Examples: "2003-12-25" or "VISIT 2".'
  :compliance: Permissible
